Syros Pharmaceuticals (SYRS)
(Delayed Data from NSDQ)
$5.35 USD
-0.49 (-8.39%)
Updated Mar 28, 2024 03:59 PM ET
After-Market: $5.36 +0.01 (0.19%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/08/2024
Time: -- |
3/2024 | $-0.88 | 0.00% |
Earnings Summary
For their last quarter, Syros Pharmaceuticals (SYRS) reported earnings of -$1.19 per share, beating the Zacks Consensus Estimate of $-1.23 per share. This reflects a positive earnings surprise of 3.25%. Look out for SYRS's next earnings release expected on May 08, 2024. For the next earning release, we expect the company to report earnings of -$0.88 per share, reflecting a year-over-year decrease of 3.53%.
Earnings History
Price & Consensus
Zacks News for SYRS
Are You Looking for a Top Momentum Pick? Why Syros Pharmaceuticals, Inc. (SYRS) is a Great Choice
SYRS: What are Zacks experts saying now?
Zacks Private Portfolio Services